Tuberculosis Market Research Reports & Industry Analysis
The Mantoux test is used in the United States and is endorsed by the American Thoracic Society and Centers for Disease Control and Prevention (CDC). Multiple puncture tests such as the Tine test are not recommended. The Mantoux test is one of the two major tuberculin skin tests for tuberculosis used in the world.
As a replacement for the Mantoux test, several other tests are being developed. QuantiFERON®-TB Gold, manufactured by Cellestis Limited (Carnegie, Victoria, Australia) is a blood test that measures the patient’s immune reactivity to the M. tuberculosis and is useful for initial and serial testing of persons with an increased risk of latent or active tuberculosis infection. Guidelines for the use of QuantiFERON-®TB Gold were released by the CDC in December of 2005. QuantiFERON®-TB Gold is FDA approved in the United States; has CE Mark approval in Europe; and has been approved by the MHLW in Japan. Sputum smears and cultures should be done for acid-fast bacilli if the patient is producing sputum. The preferred method for this is fluorescence microscopy (auramine-rhodamine staining), which is more sensitive than conventional Ziehl- Neelsen staining.
Tuberculosis Industry Research & Market Reports
-
Point of Care (PoC) Molecular Diagnostics Market Analysis and Forecast to 2031: By Technology (PCR, In Situ Hybridization, Sequencing, Isothermal Amplification), By Application (Infectious Disease, {Flu, Respiratory Syncytial Virus (RSV), Tuberculosis (TB), HIV, Gonorrhoea, Chlamydia, Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region
... Hepatitis C, Hepatitis B}, Oncology, Hematology), By End-use (Hospitals, Clinics) and Region The global pulse oximeter market was valued at USD 2.2 billion in 2021 and it is anticipated to grow up to USD 2.6 ... Read More
-
Middle East and Africa Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The MEA Anti-infective agents market was valued at US$ 8,188.65 million in ... Read More
-
Europe Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The Europe anti-infectives agents market is likely to be US$ 41,446.62 million in 2022 and ... Read More
-
North America Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The anti-infective agents market in North America is expected to grow from US$ 45,331.11 ... Read More
-
Asia Pacific Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Others), Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The APAC anti-infective agents market was valued at US$ 35,281.27 million in 2022 and ... Read More
-
Emerging Infectious Disease Market Trends, 2022
... as possibilities for the next threat. The search is constant, and is by no means limited to respiratory epidemics. As the recent monkeypox concern has demonstrated, little-known pathogens can emerge and become large health threats. ... Read More
-
Global Latent Tuberculosis Infection (LTBI) Testing Market: Analysis By Type (Tuberculin Skin Test LTBI Testing and Interferon Gamma Released Assay (IGRA) LTBI Testing), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2027
... to 2027 The global latent tuberculosis infection (LTBI) testing market in 2021 was valued at US$1.75 billion. The market value is expected to reach US$2.47 billion by 2027. Latent Tuberculosis tests diagnose latent tuberculosis which ... Read More
-
Infectious Disease Diagnostics Market Analysis and Forecast to 2031: By Product & Service (Assays, Kits & Reagents, Instruments, Services & Software), Technology (Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Isothermal Nucleic Acid Amplification Technology, DNA Sequencing & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and Region
... & Next Generation Sequencing, DNA Microarray, Others), Diseases Type (Hepatitis, Human Immunodeficiency Virus, Chlamydia Trachomatis Genital Infection & Gonorrhea, Hospital Acquired Infections, Human Papillomavirus, Tuberculosis, Influenza, Others), End Use (Hospitals/Clinical Laboratories, Reference Laboratories, Others), and ... Read More
-
Anti-Infective Agents Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Anti-Viral, Anti-Bacterial, Anti-Fungal, and Others), Range (Narrow Spectrum and Broad Spectrum), Route of Administration (IV, Oral, Topical, and Others) Indication (HIV, Tuberculosis, Respiratory Infection, Pneumonia, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others)
... Tuberculosis, Respiratory Infection, Pneumonia, and Others) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, and Others) The anti-infective agents market is expected to grow from US$ 1,35,961.03 million in 2022 to US$ 1,64,196.61 ... Read More
-
Global Bovine Tuberculosis Diagnosis Market Size study, by Test Type (Serological Tests, Molecular Diagnostic Tests, Traditional Tests) and Regional Forecasts 2022-2028
... is anticipated to grow with a healthy growth rate of more than 4.2 % over the forecast period 2022-2028. Mycobacterium bovis causes bovine tuberculosis (bTB). Bovine TB is most common in Africa, and while it ... Read More
-
Global Infectious Disease Diagnostics Market Size study, By Product (Reagents, Kits, and Consumables, Instruments, Software & Services), By Technology (Immunodiagnostics, Clinical Microbiology, PCR, INAAT, Other technologies), By Disease Type (HIV, Hepatitis, HPV, Tuberculosis, Influenza, Other Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028
... Infectious Diseases), By End-User (Diagnostic Laboratories, Hospitals & Clinics, Other End-Users), and Regional Forecasts 2022-2028Global Infectious Disease Diagnostics Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a ... Read More
-
Infectious Disease Diagnostics Market by Product (Reagents, Kits, Instrument, Software), Test Type (Lab, POC), Disease (COVID-19, Flu, HAIs, HIV, HPV), Technology (Immunodiagnostics, NGS, INAAT, PCR), End User (Hospitals, Labs) - Global Forecast to 2027
... global infectious disease diagnostics market size is projected to reach USD 33.1 billion by 2027 from USD 35.5 billion in 2022, at a -1.4% CAGR.Market is driven by factors such as indication of infectious diseases, ... Read More
-
2022 Global Forecast for Anti-Tuberculosis Drug Market (2023-2028 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2022 to USD xx billion by 2028, at a CAGR of xx% from 2023 to 2028. Estimates on equipment or material sales (product ... Read More
-
Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and by Region (North America, Latin America, Europe, As
... Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Tuberculosis is a common infectious disease caused by mycobacterium tuberculosis that affects the lungs. The treatment ... Read More
-
Breathalyzers Market, By Technology (Fuel Cell, Semiconductor Sensor, Infrared Absorption), By Application (Alcohol Detection, Tuberculosis Detection, Detection for H.pylori Infection, Drug Testing, Asthma Detection, Others), and By Region (North America,
... Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Alcohol and drug testing equipment are used to test the level of intoxication caused by alcohol and drug in the body. ... Read More
-
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2022 Including: 1) By Product: Instruments And Devices; Assays And Reagents 2) By Test Type: Traditional Diagnostic Tests; Mechanical Tests; Imaging Tests; Molecular Diagnostic Tests 3) By Disease Type: Chronic Obstructive Pulmonary Disease; Lung Cancer; Asthma; Tuberculosis; Other Diseases 4) By End User: Hospital/Clinical Laboratories; Physician Offices; Reference Laboratories; Other End Users Covering: ResMed Inc.; Medtronic plc.; Massimo Corporation; Fisher & Paykel Healthcare Limited; Koninklijke Philips N.V.; Smiths Medical
... need to assess the global respiratory devices and equipment (diagnostic) market. This report focuses on respiratory devices and equipment (diagnostic) market which is experiencing strong growth. The report gives a guide to the respiratory devices ... Read More
-
The 2023-2028 World Outlook for Tuberculosis Treatment Drugs
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2023-2028 World Outlook for Tuberculosis Therapeutics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Tuberculosis Testing
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Tuberculosis Diagnostics
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2023-2028 World Outlook for Respiratory Diagnostics for Tuberculosis
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Tuberculosis Testing Chest X-Rays
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2023-2028 World Outlook for Communicable Diseases
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Global Respiratory Pathogen Testing Market Size study, by Diseases (Tuberculosis, Asthma, Lung Cancer, Chronic Obstructive Pulmonary Diseases, Others), by End-Use (Hospital Clinical Laboratories, Reference Laboratories, Physician Offices, Others) and Regional Forecasts 2022-2028
... Testing Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.00% over the forecast period 2022-2028. A respiratory pathogens (RP) panel ... Read More
-
Infectious Disease Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Kits and Reagents, Instruments, and Software and Service ss), Disease Indication [HIV, Hepatitis, Healthcare- Associated Infections (HAIs), Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, and Others Disease Indications ], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and, Point of Care Testing), End User (Hospitals and Clinics, Pathology or Diagnostic Laboratories, Research Institutes, Home-Care Settings, and Others End User), and Geography
... Tuberculosis (TB), Influenza, and Others Disease Indications ], Technology (Immunodiagnostics, Polymerase Chain Reaction, Next Generation Sequencing, Clinical Microbiology, and Others), Testing Type (Laboratory Testing and, Point of Care Testing), End User (Hospitals and Clinics, Pathology ... Read More
Research Assistance
